These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 9815916)

  • 21. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.
    Xiao YJ; Schwartz B; Washington M; Kennedy A; Webster K; Belinson J; Xu Y
    Anal Biochem; 2001 Mar; 290(2):302-13. PubMed ID: 11237333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer.
    Goetzl EJ; Dolezalova H; Kong Y; Hu YL; Jaffe RB; Kalli KR; Conover CA
    Cancer Res; 1999 Oct; 59(20):5370-5. PubMed ID: 10537322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis.
    Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis.
    Jalink K; Hengeveld T; Mulder S; Postma FR; Simon MF; Chap H; van der Marel GA; van Boom JH; van Blitterswijk WJ; Moolenaar WH
    Biochem J; 1995 Apr; 307 ( Pt 2)(Pt 2):609-16. PubMed ID: 7733903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
    Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
    Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer.
    Tanyi JL; Hasegawa Y; Lapushin R; Morris AJ; Wolf JK; Berchuck A; Lu K; Smith DI; Kalli K; Hartmann LC; McCune K; Fishman D; Broaddus R; Cheng KW; Atkinson EN; Yamal JM; Bast RC; Felix EA; Newman RA; Mills GB
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3534-45. PubMed ID: 14506139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrations in normal systemic lipid metabolism in ovarian cancer patients.
    Gercel-Taylor C; Doering DL; Kraemer FB; Taylor DD
    Gynecol Oncol; 1996 Jan; 60(1):35-41. PubMed ID: 8557225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
    Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
    Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Dependence on acyl-chain length and inhibition by suramin.
    van Corven EJ; van Rijswijk A; Jalink K; van der Bend RL; van Blitterswijk WJ; Moolenaar WH
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):163-9. PubMed ID: 1731751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular lipid metabolism influences the survival of ovarian cancer cells.
    Kuwata S; Ohkubo K; Kumamoto S; Yamaguchi N; Izuka N; Murota K; Tsujiuchi T; Iwamori M; Fukushima N
    Biochem Biophys Res Commun; 2013 Sep; 439(2):280-4. PubMed ID: 23973712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
    Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
    Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lysophosphatidic acid in malignant ascites stimulates migration of human mesenchymal stem cells.
    Lee MJ; Jeon ES; Lee JS; Cho M; Suh DS; Chang CL; Kim JH
    J Cell Biochem; 2008 May; 104(2):499-510. PubMed ID: 18027882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lysophosphatidic acid, but not phosphatidic acid, is a potent Ca2(+)-mobilizing stimulus for fibroblasts. Evidence for an extracellular site of action.
    Jalink K; van Corven EJ; Moolenaar WH
    J Biol Chem; 1990 Jul; 265(21):12232-9. PubMed ID: 2373690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment.
    Reinartz S; Lieber S; Pesek J; Brandt DT; Asafova A; Finkernagel F; Watzer B; Nockher WA; Nist A; Stiewe T; Jansen JM; Wagner U; Konzer A; Graumann J; Grosse R; Worzfeld T; Müller-Brüsselbach S; Müller R
    Mol Oncol; 2019 Feb; 13(2):185-201. PubMed ID: 30353652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells.
    Sengupta S; Xiao YJ; Xu Y
    FASEB J; 2003 Aug; 17(11):1570-2. PubMed ID: 12824286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence of lysophosphatidic acid and its alkyl ether-linked analog in rat brain and comparison of their biological activities toward cultured neural cells.
    Sugiura T; Nakane S; Kishimoto S; Waku K; Yoshioka Y; Tokumura A; Hanahan DJ
    Biochim Biophys Acta; 1999 Sep; 1440(2-3):194-204. PubMed ID: 10521703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lysophosphatidic acid signaling in ovarian cancer.
    Jesionowska A; Cecerska-Heryc E; Matoszka N; Dolegowska B
    J Recept Signal Transduct Res; 2015; 35(6):578-84. PubMed ID: 26393967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.